Work Package 4

Objectives

We seek to:

• Conduct an analysis of the intervention cost of ePAMS+
• Estimate the cost-effectiveness of ePAMS+ in terms of cost per unit change in defined daily dose (DDD)
• Model the effect of any reduction in DDD on the health outcomes such as Clostridium Difficile Diarrhoea (CDD), using estimates from the literature to populate the model
• Estimate the cost utility of e PAMS+ from a one year, health services, perspective
• Conduct sensitivity analyses
• Contribute to an International effort to calibrate the economic case for antimicrobial resistance control and hence for the health economics of a particular contribution (such as that of ePAMS+)

For further information contact Professor Richard Lilford (r.j.lilford@bham.ac.uk)